Tonix raises $144M in a direct offering following positive PhIII data for its fibromyalgia drugnews2023-12-21T16:11:08+00:00December 21st, 2023|Endpoints News|
J&J buys eye disease gene therapy from MeiraGTxnews2023-12-21T16:00:59+00:00December 21st, 2023|Endpoints News|
Lilly partners with startup Fauna Bio to see if a squirrel’s hibernation could lead to new obesity drugsnews2023-12-21T13:00:47+00:00December 21st, 2023|Endpoints News|
BioMarin strikes cooperation deal with activist investor Elliott, sets up review committee and adds board membersnews2023-12-21T12:18:05+00:00December 21st, 2023|Endpoints News|
Immunovant unveils positive early data for PhII Graves’ disease drugnews2023-12-21T12:18:04+00:00December 21st, 2023|Endpoints News|
FDA hands CRL to Merck’s chronic cough drug over efficacy questionsnews2023-12-21T11:05:02+00:00December 21st, 2023|Endpoints News|
Deck the halls with resignations: LianBio CEO, CFO out; CRISPR Therapeutics CMO to leave in Januarynews2023-12-21T10:30:26+00:00December 21st, 2023|Endpoints News|
Sanofi to end tusamitamab ravtansine development after ADC fails PhIII lung cancer trialnews2023-12-21T08:52:07+00:00December 21st, 2023|Endpoints News|
Bristol Myers gets regulatory clearance to close Mirati deal as FTC increases pressure on pharma M&Anews2023-12-20T20:31:09+00:00December 20th, 2023|Endpoints News|
AbbVie files trade secrets suit against Adcentrx and former employeenews2023-12-20T20:25:04+00:00December 20th, 2023|Endpoints News|
